HomePharmaceutical

Pharmaceutical

DHL invests US$15m in Singapore pharma hub to bolster supply chains

DHL has committed US$15 million to launch its first pharmaceutical logistics facility in Southeast...

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...

BD tackles shortage in healthcare professionals with robot pharmacy technology

Singapore hospitals are deploying robotic pharmacy technology to ease healthcare workforce shortages, cut patient...

Latest articles

All-Link Air & Sea’s 1H FY2026 Revenue Surges But One-Off IPO Costs Hit Bottom Line

All Link Numbers Show Growth Beyond the IPO Noise All-Link Air & Sea Limited has...

Datapulse Technology Faces Voluntary Delisting Despite Reporting 33% Profit Growth In FY2026

Datapulse Technology Surges in Profit Amid Upcoming SGX Delisting Datapulse Technology Limited delivered a superficially...

Profit Triples At Del Monte Pacific As Restructuring Efforts Take Center Stage In 1Q FY2027

High Profits Mask Capital Struggles While the operational engine of Del Monte Pacific Limited is...

Willas-Array Electronics 1H FY2026 Profits Surge 196%

Willas-Array Electronics Triples Profits as Strategic Pivot Hits High Gear Willas-Array Electronics (Holdings) Ltd has...

Keep exploring

All-Link Air & Sea’s 1H FY2026 Revenue Surges But One-Off IPO Costs Hit Bottom Line

All Link Numbers Show Growth Beyond the IPO Noise All-Link Air & Sea Limited has officially pulled back the curtain on its first set of financial results since its August 2026 listing on the SGX Mainboard. For investors, these 1H FY2026 numbers offer a fascinating...

Datapulse Technology Faces Voluntary Delisting Despite Reporting 33% Profit Growth In FY2026

Datapulse Technology Surges in Profit Amid Upcoming SGX Delisting Datapulse Technology Limited delivered a superficially impressive set of full-year results for FY2026, headlined by a 33% surge in profit attributable to owners. The bottom line reached $1.09 million, up from $0.82 million in the prior...

Keep exploring